Business
Avicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia
Avicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compou...
About this update from Avicanna Inc
[{"type":"text","content":"\n\n\n\nAvicanna's subsidiary obtains GPP certification and authorization by INVIMA for the compounding and sale of pharmaceutical cannabinoid products with medical prescriptions in Colombia\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO, Sept. 14, 2020\n\n\n\n/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/\nAuthorized cannabinoid products will be available to the medical community and patients in early Q4 2020 including Avicanna's advanced oral, sublingual, and topical formulations branded and sold as RHO Phyto™ in Canada and other markets. This is the first ever compound pharmacy in Colombia authorized to specialize only in the production of cannabinoid formulations and the first authorized to offer topicals. This is the final step in Avicanna's fully integrated seed to patient business model in Colombia, which includes cultivation, extraction and manufacturing of pharmaceutical products for the emerging medical market with the 50 million people. TORONTO, Sept. 14, 2020 /CNW/ - Avicanna Inc. (\"Avicanna\" or the \"Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products announces that through its wholly owned subsidiary Avicanna LATAM S.A.S. (\"Avicanna LATAM\"), the Company's pharmacy in Bogota has been certified with Good Preparation Practices (\"GPP\") and authorized by the National Institute for Drug and Food Surveillance (\"INVIMA\") for the sale of compounded pharmaceutical products to service medical prescriptions of individual patients in Colombia.\n\n \n \n \n \n \n \n\n \n\"We are thrilled to be able to offer our pharmaceutical preparations to the Colombian medical and patient communities. While the medical cannabis market in Colombia is still in its infancy, we are committed to educating both physicians and the medic...